Head of Investor Relations
Hims & Hers Health, Inc. (HIMS)Equibles does not estimate personal net worth.
Get an email with a short summary when Hims & Hers Health, Inc. publishes a filing, an earnings call transcript or a press release.
Get HIMS alertsBill Newby is recorded as Head of Investor Relations at Hims & Hers Health, Inc. (HIMS). Bill Newby has spoken on 12 earnings calls across 1 company, most recently for Hims & Hers Health, Inc. on November 9, 2026. Hims & Hers Health, Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Hims & Hers Health, Inc. includes Andrew Dudum (CEO and Board Member), Mr. Dudum (CEO), Irene A. Becklund (CFO) and 7 others.
“Good afternoon, everyone, and welcome to the Hems and Hers Health Third Quarter 2026 Earnings Call. On the call with me today is Andrew Dudham, our co-founder and chief executive officer, Yemi Okupe, our chief financial officer, and Mo Elshinawi, our chief technology officer.”
“Good afternoon, everyone, and welcome to the Hims and Hers Health second quarter 2026 earnings call. On the call with me today is Andrew Dudum, our co-founder and chief executive officer, Yemi Okupe, our chief financial officer, and Mo Elshanawi, our chief technology officer.”
“Good afternoon, everyone, and welcome to the Hems and Hers Health first quarter 2026 earnings call. Before we dive in, I want to provide an update on our approach to earnings communications.”
“Good afternoon, everyone, and welcome to the HIMS and HERS Health fourth quarter and full year 2025 earnings call.”
“Good afternoon, everyone, and welcome to the Hems and Hers Health Third Quarter 2025 Earnings Call.”
Drug Manufacturers - Specialty & Generic · Healthcare
Head of Investor Relations
